On the other hand, the risks of HHF (HR 0.93, 95% CI 0.831.04 with GLP-1RAs and HR 0.69, 95% CI 0.610.79 with SGLT2is) and composite kidney outcomes excluding macroalbuminuria (HR 0.92, 95% CI 0.801.06 with GLP-1RAs and HR 0.55, 95% CI 0.480.64 with SGLT2is) significantly reduced with SGLT2is only
The companys collaboration with Novo will focus on single- and multiple-receptor-targeting drugs, exploring all possible binding sites
Multiple medications now exist, each with slightly different properties
Long-acting preparations include lixisenatide (LIXI) and LIR, which are injected once a day
The HPA axis in bipolar disorder: systematic review and meta-analysis
Avoid Unregulated Skin-Lightening Products This is especially important